Whole-genome optical mapping to elucidate myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions

Affiliations

• ¹ CHU Lille, Institute of Medical Genetics, France. Electronic address: [email protected].
• ² CHU Lille, Institute of Medical Genetics, France.
• ³ CHU Lille, Laboratory of Hematology, France.
• ⁴ CHU Lille, Internal Medicine and Immunology, Centre de reference des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), France; U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
• ⁵ CH Arras, Hematology Department, France.
• ⁶ CH Arras, Laboratory of Hematology, France.
• ⁷ CHU Lille, Laboratory of Hematology, France; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France.
• ⁸ CHU Lille, Institute of Medical Genetics, France; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France.